Mytide Therapeutics

company

About

Mytide Therapeutics is committed to providing peptides to serve a diverse array of applications.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$7M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Mytide is committed to providing peptides to serve a diverse array of applications. They intend to work closely with partners to overcome challenges in synthesizing and purifying particular classes of peptides of interest, identify useful peptide modifications, and design and construct peptide libraries. They provide initial partners access to their cloud platform for immediate ordering, properties calculator, order tracking, and interactive data display.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$7.26M
Mytide Therapeutics has raised a total of $7.26M in funding over 2 rounds. Their latest funding was raised on Mar 8, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 8, 2022 Series A $7M 1 Alloy Therapeutics Detail
Dec 13, 2019 Grant $269.96K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Mytide Therapeutics is funded by 2 investors. Alloy Therapeutics and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
Alloy Therapeutics Yes Series A
National Science Foundation Yes Grant